Efficacy and safety of remote cardiac rehabilitation in the recovery phase of cardiovascular diseases (RecRCR study): A multicenter, nonrandomized, and interventional trial in Japan.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Itoh Hidetaka, Amiya Eisuke, Jimba Takahiro, Shimbo Mai, Narita Koichi, Taya Masanobu, Kadokami Toshiaki, Yasu Takanori, Oka Hideki, Sogawa Masakazu, Yokoi Hiroyoshi, Mizutani Kazuo, Miura Shin-Ichiro, Tokeshi Tatsuo, Date Ayumi, Noma Takahisa, Kutsuzawa Daisuke, Usui Soichiro, Sugawara Shigeo, Kanazawa Masanori, Sekino Hisakuni, Nishitani Yokoyama Miho, Okumura Takahiro, Ugata Yusuke, Fujishima Shinichiro, Hirabayashi Kagami, Ishizaki Yuta, Kuwahara Koichiro, Kaji Yuko, Shimizu Hiroki, Koyama Teruyuki, Adachi Hitoshi, Kurumatani Yoko, Taniguchi Ryoji, Ohori Katsuhiko, Shiraishi Hirokazu, Hasegawa Takashi, Makita Shigeru, Komuro Issei, Kimura Yutaka, RecRCR registry investigators
Аннотация
METHODS: This multicenter, nonrandomized, interventional study was conducted at 29 institutions across Japan and enrolled patients with cardiovascular diseases who met indications for cardiac rehabilitation (CR) after receiving in-hospital treatment. The RCR group exercised at home using an ergometer and was monitored in real-time using interactive video and monitoring tools for 2-3 months. Educational instructions were provided concurrently through e-learning approaches. The safety of the RCR protocol and the improvement in peak oxygen consumption (VO2) were compared with those of the historical control group that participated in center-based CR.
RESULTS: Fifty-three patients from the RCR group were compared with 103 historical controls having similar background characteristics. No patients in RCR experienced significant cardiovascular complications while engaging in exercise sessions. After 2-3 months of RCR, the peak VO2 improved significantly, and the increases in the RCR group did not exhibit any significant differences compared to those in the historical controls. During follow-up, the proportion of patients whose exercise capacity increased by 10% or more was also evaluated; this finding did not indicate a statistically significant distinction between the groups.
CONCLUSIONS: RCR during the recovery phase of cardiovascular diseases proved equally efficient and safe as center-based CR.